By: Anna Zink, PhD; David Wehrly, MA; Debra Bozzi, PhD; Amanda Sutherland, PhD; Emily Boudreau, PhD; J. Michael McWilliams, MD, PhD; Michael Chernew, PhD

Prescription Use and Spending After the Introduction of a Real-Time Prescription Benefit Tool 

none

 Washington Consumer Health Privacy Policy 

Prescription Use and Spending After the Introduction of a Real-Time Prescription Benefit Tool

California Consumer Privacy Act (CCPA) Opt-Out Icon

prescription-use-and-spending-after-the-introduction-of-a-real-time-prescription-benefit-tool 

A smiling young male doctor is working in the office of the clinic using a laptop. Sitting in a white coat at the desk, typing, texting. Close-up photo.

A smiling young male doctor is working in the office of the clinic using a laptop. Sitting in a white coat at the desk, typing, texting. Close-up photo

By: Shireen Haq, MPH; Qianli Ma, MS; Zhaoyi Chen, PhD; Andrea DeVries, PhD; Emily Boudreau, PhD; Robert Burke, MD, MS; Eric Roberts, PhD 

The Voice of the Beneficiary: Perspectives on Supplemental Benefits

By: Kaylyn Swankoski, PhD, Amanda Sutherland, PhD, Emily Boudreau, PhD, Suhas Gondi, MD, MBA, Vivek Kumar Garg, MD, MBA, Shannon Burdette, and Gosia Sylwestrzak, MA

Doctor and senior patient using digital tablet

Improving Primary Care Use by Seniors Through Value-Based Care

By: Insiya B. Poonawalla, MS, PhD, Petir Abdal, PharmD, MBA, Mary Hayes, PharmD, BCPS, Isha John, PharmD, MBA, Monica Diaz, PharmD, RPh, BCPS, Suzanne Dixon, MPH, MS, RDN, and Andy Bowe, MPH

health-care-resource-utilization-and-costs-in-medicare-advantage-beneficiaries-using-glucagon-like-peptide-1-receptor-agonists-vs-sodium-glucose-cotransporter-2-inhibitors

Man making Injection in her Stomach. Semaglutide or Insulin Injection Diabetes Drug 

Health care resource utilization and costs in Medicare Advantage beneficiaries using glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter-2 inhibitors